Search - tctmd.com

Displaying 141 - 156 of 156

Sort: Relevancy | Date

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

News Daily News

Edwards Lifesciences Pauses Transcatheter Mitral Valve Study to Work Out Design Issues

Michael O'Riordan

February 07, 2017

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

Caitlin E. Cox

February 06, 2017

Presentation ISET 2017

IVC Filters in the Setting of PE: Who and When?

Presenter: Akhilesh Sista

February 04, 2017

Presentation ISET 2017

Anticoagulation Following DVT: Agents and Length of Treatment

Presenter: Ian del Conde

February 04, 2017

Presentation ISET 2017

Who Should Undergo Deep Vein thrombosis Lysis? A Review of The Trial Data

Presenter: William T. Kuo

February 04, 2017

News Daily News

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Michael O'Riordan

February 03, 2017

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

News Daily News

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Michael O'Riordan

January 20, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

Presentation CCVVC 2016

Timing of DAPT Interruption and DES Thrombosis

Presenter: Usman Baber

June 16, 2016

Presentation CCVVC 2016

Subclinical Leaflet Thrombosis Post-TAVR

Presenter: Gian Paolo Ussia

June 16, 2016

News Daily News

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Michael O'Riordan

January 12, 2016

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Daily News

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Kim Dalton

August 30, 2009

CME

Advertisement

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

Edwards Lifesciences Pauses Transcatheter Mitral Valve Study to Work Out Design Issues

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

IVC Filters in the Setting of PE: Who and When?

Anticoagulation Following DVT: Agents and Length of Treatment

Who Should Undergo Deep Vein thrombosis Lysis? A Review of The Trial Data

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Timing of DAPT Interruption and DES Thrombosis

Subclinical Leaflet Thrombosis Post-TAVR

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content